INVITRO SELECTION OF VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE

被引:152
|
作者
GAO, Q
GU, ZX
PARNIAK, MA
LI, XG
WAINBERG, MA
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST,3755 CHEMIN COTE STE CATHERINE,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] MCGILL UNIV,MCGILL AIDS CTR,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
D O I
10.1128/JVI.66.1.12-19.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Drug-resistant variants of human immunodeficiency virus type 1 (HIV-1) have been isolated by in vitro selection. MT-4 cells were infected with either a laboratory strain (HIV-III(B)) or a clinical isolate (no. 187) of HIV-1 and maintained in medium containing subeffective concentrations of the drugs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxyinosine (ddI). By gradually increasing the drug concentration in the culture medium during propagation of the virus on fresh MT-4 cells, we were able to isolate variants of HIV-III(B) and clinical isolate 187 which showed up to 100-fold increases in resistance to the drugs. The drug resistance phenotypes remained stable after propagation of the variants in the absence of drug pressure for over 2 months. However, variants resistant to one drug showed little or no cross-resistance to the other, suggesting that the genetic bases for resistance to the compounds differed. Genotypic analysis of these nucleoside-resistant variants by polymerase chain reaction (PCR) with primer pairs previously shown to correspond to mutations responsible for resistance to AZT was also carried out. A heterogeneity of genotypes was observed, with known mutations at pol codons 70 and 215 occurring in most of the AZT-resistant variants generated from either HIV-III(B) or clinical strain 187. However, mutations in codons 67 and 219 were less frequently detected, and none of these changes were observed in each of four variants resistant to ddI. Cloning and sequencing studies of the reverse transcriptase coding region of two of the isolates were also performed and confirmed the PCR data that had been obtained. In addition to previously described mutation sites responsible for resistance to AZT, and HIV-III(B)-resistant variant was shown to be mutated at positions 108 (Val --> Ala) and 135 (Ile --> Thr), while a resistant variant of strain 187 was mutated at positions 50 (Ile --> Val) and 135 (Ile --> Val).
引用
收藏
页码:12 / 19
页数:8
相关论文
共 50 条
  • [1] INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE
    DIANZANI, F
    ANTONELLI, G
    TURRIZIANI, O
    DONG, GM
    CAPOBIANCHI, MR
    RIVA, E
    ANTIVIRAL RESEARCH, 1992, 18 (01) : 39 - 52
  • [2] SELECTION AND CHARACTERIZATION OF MUTANTS OF FELINE IMMUNODEFICIENCY VIRUS RESISTANT TO THE COMBINATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2', 3'-DIDEOXYINOSINE
    GOBERT, JM
    REMINGTON, KM
    ZHU, YQ
    NORTH, TW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 78 - 78
  • [3] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY PHOSPHONOFORMATE ESTERS OF 3'-AZIDO-3'-DEOXYTHYMIDINE
    ROSOWSKY, A
    SAHA, J
    FAZELY, F
    KOCH, J
    RUPRECHT, RM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (01) : 288 - 294
  • [4] EFFECT OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE ON ESTABLISHMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CULTURED CD8(+) LYMPHOCYTES
    MERCURE, L
    BRENNER, BJ
    PHANEUF, D
    TSOUKAS, C
    WAINBERG, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) : 986 - 990
  • [5] ACTIVITIES OF (-)-CARBOVIR AND 3'-AZIDO-3'-DEOXYTHYMIDINE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS INVITRO
    CARTER, SG
    KESSLER, JA
    RANKIN, CD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1297 - 1300
  • [6] EFFECT OF 3'-AZIDO-3'-DEOXYTHYMIDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN HUMAN FETAL BRAIN MACROPHAGES
    GELEZIUNAS, R
    ARTS, EJ
    BOULERICE, F
    GOLDMAN, H
    WAINBERG, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) : 1305 - 1312
  • [7] SYNERGISTIC INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 REPLICATION INVITRO BY CASTANOSPERMINE AND 3'-AZIDO-3'-DEOXYTHYMIDINE
    JOHNSON, VA
    WALKER, BD
    BARLOW, MA
    PARADIS, TJ
    CHOU, TC
    HIRSCH, MS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) : 53 - 57
  • [8] ACTIVITIES OF 3'-AZIDO-3'-DEOXYTHYMIDINE NUCLEOTIDE DIMERS IN PRIMARY LYMPHOCYTES INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SCHINAZI, RF
    SOMMADOSSI, JP
    SAALMANN, V
    CANNON, DL
    XIE, MY
    HART, GC
    SMITH, GA
    HAHN, EF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1061 - 1067
  • [9] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE BY 3'-AZIDO-3'-DEOXYTHYMIDYLATE
    MAZUMDER, A
    COONEY, D
    AGBARIA, R
    GUPTA, M
    POMMIER, Y
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) : 5771 - 5775
  • [10] SANCTUARY GROWTH OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE PRESENCE OF 3'-AZIDO-3'-DEOXYTHYMIDINE
    MEDINA, DJ
    TUNG, PP
    LERNERTUNG, MB
    NELSON, CJ
    MELLORS, JW
    STRAIR, RK
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1606 - 1611